Alignment Healthcare (ALHC)

Generated: July 25, 2026

Yellow Dot

Statistics

Metric	Value
Last Close	$14.84
Blended Price Target	20.88
Blended Margin of Safety	40.7% Undervalued
Rule of 40 (Next)	55.2%
Rule of 40 (Current)	61.8%
FCF-ROIC	29.8%
Sales Growth Next Year	25.4%
Sales Growth Current Year	32.0%
Sales 3-Year Avg	41.2%
Industry	Healthcare Plans

Analysis

Alignment Healthcare looks like a focused, fast-growing Medicare Advantage specialist with a credible path to scale and improving profitability. Its revenue base is highly recurring, tied to government-funded premiums for seniors, and recent quarters show strong membership and revenue growth alongside better medical cost control.^[6]^[8] The core question is whether the company can preserve this momentum while navigating increasingly challenging Medicare Advantage reimbursement and regulatory scrutiny.^[10]

The business shows early signs of durable growth: membership has been expanding rapidly, revenue surpassed $1 billion in the latest reported quarter, and the company has moved from consistent losses to its first quarterly profit in 2025.^[6]^[8] This suggests a model that can scale and become sustainably profitable if execution remains disciplined. However, its moat is still developing; Alignment competes against national incumbents with massive scale, though it differentiates through a tech-enabled, senior-centric care model and a narrow-plan strategy in select markets.^[5]^[10] Leadership appears execution-oriented and willing to trade near-term margins for long-term growth, but the business remains sensitive to policy changes and competitive intensity.

What the Company Does

Alignment Healthcare is a technology-enabled health insurance company focused almost entirely on Medicare Advantage plans for seniors. It contracts with the federal government to provide managed-care coverage, using a care model centered on high-risk seniors, data analytics, and its proprietary clinical platform to coordinate care and manage medical costs.^[5]^[10]

The company generates revenue primarily from capitated premiums paid by the Centers for Medicare & Medicaid Services (CMS) and, to a lesser extent, from related programs and services. Recent disclosures emphasize that growth is driven by Medicare Advantage membership expansion and premium rate dynamics rather than diversified business lines, so the mix is effectively dominated by health plan premiums, with only a small contribution from other revenue streams.^[5]^[6]^[8]

Revenue Recurrence & Predictability

Alignment’s revenue is fundamentally contractual and recurring, based on per-member-per-month (PMPM) payments from CMS for Medicare Advantage beneficiaries it enrolls. Once a member is enrolled, payments are highly predictable over the coverage year, subject primarily to risk adjustment, star ratings, and medical utilization rather than discretionary consumer spending.^[5]^[6]^[8]

Churn exists because members can switch plans annually, but Medicare Advantage tends to have relatively stable enrollment patterns, particularly when plans offer competitive benefits and strong service. Alignment’s emphasis on high-touch care for complex seniors may further reduce churn and increase lifetime member value, but the company is still scaling, so membership volatility and regional contract dynamics remain meaningful factors.^[5]^[10]

Revenue Growth Durability

Alignment’s growth outlook is underpinned by the long-term expansion of Medicare Advantage, which continues to take share from traditional Medicare and benefits from demographic tailwinds as the U.S. population ages. Management has guided to continued strong revenue growth into 2026, with expectations of revenue exceeding $5 billion, implying robust continued expansion from its current scale.^[10]^[8] This suggests above-market growth is likely in the near to medium term.

Longer term, growth durability will depend on how effectively Alignment penetrates existing and new markets while maintaining medical cost discipline. Key levers include entering additional counties and states, launching new plan designs, improving star ratings, and deepening relationships with provider groups. Headwinds include reimbursement pressure, tightening CMS rules, and intensifying competition from large national payers and other value-based care entrants, which could gradually temper growth if not offset by strong execution.^[10]^[5]

Economic Moat

Alignment’s emerging moat rests on clinical model differentiation, data and analytics, and local provider partnerships rather than traditional scale. The company positions itself as a “senior-first” platform, integrating 24/7 care teams, home visits, and predictive analytics to manage high-risk members.^[5]^[10] This can create better outcomes and lower costs, which are attractive to both CMS and provider partners.

However, the moat is still modest compared with entrenched incumbents like UnitedHealthcare and Humana, which enjoy larger scale economies, stronger negotiating leverage, and entrenched broker relationships. Alignment’s advantage may widen if it continues to show superior medical cost ratios and member satisfaction in its core markets, building stronger provider networks and brand equity, but the Medicare Advantage space remains structurally competitive, limiting the depth of any defensible moat.^[6]^[9]^[10]

Management & Leadership

Alignment Healthcare is founder-led; CEO John Kao founded the company and has stewarded it from startup through rapid public-company growth.^[10] Founder leadership often brings a long-term orientation and deep alignment with the mission of serving complex seniors, which is central to the company’s culture and strategy.

Recent years show management executing on a clear playbook: expanding membership, improving medical benefit ratios, and progressing from sizable losses in 2024 to a near-breakeven year in 2025 and a first quarterly profit in 2025.^[6]^[10] While specific insider ownership levels are not highlighted in the recent six-month sources, capital allocation has prioritized growth investments and disciplined geographic expansion rather than diversification into unrelated lines, suggesting a focused, execution-driven leadership approach.

Key Risks

The most significant risk is regulatory and reimbursement exposure. Alignment is heavily dependent on Medicare Advantage policy, including CMS risk adjustment rules, star ratings methodology, and benchmark payment rates.^[10] Adverse changes could compress margins or slow growth, and the ongoing scrutiny of Medicare Advantage coding practices introduces compliance and audit risk.

A second major risk is competitive intensity. Alignment competes against large national insurers with far greater scale, marketing budgets, and established distribution channels. If these incumbents aggressively price benefits or brokers shift their focus, Alignment could face slower enrollment growth or higher acquisition costs, particularly in overlapping geographies.^[5]^[10]

Operationally, the company must manage medical cost trend and execution risk. Its model depends on accurately underwriting high-risk seniors, maintaining a favorable medical benefit ratio, and avoiding adverse selection. Missteps in network management, data analytics, or care coordination could erode margins quickly, especially given the concentration in a single line of business and the need to continually prove its value-based care model at scale.^[6]^[9]

Sources

Featured in GreenDot Stocks Analysis

GreenDot Stocks Screen Update — Week of July 25, 2026 July 25, 2026
GreenDot Stocks Screen Update — Week of July 17, 2026 July 17, 2026
GreenDot Stocks Screen Update — Week of July 11, 2026 July 11, 2026
GreenDot Stocks Screen Update — Week of July 4, 2026 July 4, 2026
GreenDot Stocks Screen Update — Week of June 27, 2026 June 27, 2026